C3 and systemic lupus erythematosus: As the activity of the SLE is the primary indicator of the pregnancy prognosis, it is recommended to monitor the SLE activity by clinical history, examination, and laboratory tests (complete blood cell count, differential cell count, urinalysis results and proteinuria, anti-DNA, C3, and C4), at least once per trimester, and by the patient's clinical status (3).